VGX-3100

Unassigned

New Medicines

Cervical dysplasia caused by human papillomavirus (HPV) types 16 and 18

Information

Therapeutic vaccine
Inovio
Inovio

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

DNA-based immunotherapy (vaccine)
Cervical cancer is the third most commonly diagnosed cancer worldwide and the fourth leading cause of cancer death in women. Cervical cancer causes around 266,000 deaths worldwide commonly in those in their 20s and 30s [2].
Cervical dysplasia caused by human papillomavirus (HPV) types 16 and 18
Intramuscular